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DOI 10.1016/j.stem.2009.03.001than in attempts to define their cellular identity, also known
as the ‘‘stem cell state’’ (Buszczak and Spradling, 2006). One
definition of the ESC state is the epigenetic state that endows
ESCs with the unique option to self-renew or to differentiate
into any cell type in the body.
It has been proposed that an epigenetic event may be rate-
limiting in the derivation of new ESC lines (Smith, 2001; Thomson
et al., 1998) and may further operate in selecting for ESCs that
adapt to standard culture conditions. An epigenomic bottleneck
might similarly explain the inefficiency inherent in generating new
ES-like cells—induced pluripotent stem (iPS) cells (Takahashi
and Yamanaka, 2006; Nakagawa et al., 2007; Park et al., 2007;
Takahashi et al., 2007; Yu et al., 2007) and epiblast stem cells
(EpiSCs) (Brons et al., 2007; Tesar et al., 2007). Stated differently,
our current understanding of the ESC state may be influenced by
the manner in which ESCs are derived and maintained. Consis-
tent with this interpretation was the recent demonstration that
the efficiency of iPS cell formation is enhanced upon addition
of valproic acid, an inhibitor of histone deacetylases, to the
culture medium (Huangfu et al., 2008).
Despite their uncertain in vivo corollary, studies using in vitro
cultured ESCs have enhanced our understanding of how stem
cells work (Bernstein et al., 2006; Ivanova et al., 2006; Chambers
et al., 2007; Ying et al., 2008). To self-renew, ESCs must stably
propagate their epigenetic patterns through cell division. Funda-
mental differences exist in the mechanisms by which mouse
ESCs (mESCs) and human ESCs (hESCs) self-renew. mESCs
respond to LIF-triggered activation of STAT3, whereas hESC
do not (Dahe´ron et al., 2004). hESCs respond to superphysiolog-
ical levels of bFGF (Levenstein et al., 2006) and to Activin A
(Vallier et al., 2005; Xiao et al., 2006) to maintain pluripotency.
The differences in culture conditions for mESCs and hESCs
might be explained by the recent finding that mouse and
human ESCs are not developmental equals, with the formerSUMMARY
Recent evidence indicates that mouse and human
embryonic stem cells (ESCs) are fixed at different
developmental stages, with the former positioned
earlier. We show that a narrow concentration of the
naturally occurring short-chain fatty acid, sodium
butyrate, supports the extensive self-renewal of
mouse and human ESCs, while promoting their
convergence toward an intermediate stem cell state.
In response to butyrate, human ESCs regress to an
earlier developmental stage characterized by a
gene expression profile resembling that of mouse
ESCs, preventing precocious Xist expression while
retaining the ability to form complex teratomas
in vivo. Other histone deacetylase inhibitors (HDACi)
also support human ESC self-renewal. Our results
indicate that HDACi can promote ESC self-renewal
across species, and demonstrate that ESCs can
toggle between alternative states in response to
environmental factors.
INTRODUCTION
Embryonic stem cells (ESCs) might be regarded as a tissue
culture artifact (Smith, 2001), plucked from the preimplantation
blastocyst and supported using culture conditions bearing little
resemblance to conditions in vivo. Even leukemia inhibitory
factor (LIF), the quintessential extracellular regulator of mouse
ESC self-renewal, is not required for development other than
for implantation (Stewart et al., 1992;Ware et al., 1995). Nowhere
is the lack of a physiological context for ESCs more pressingCell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc. 359
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HDACi and hESC Self-RenewalFigure 1. Butyrate Supports the Self-
Renewal of H1 Cells
(A) H1 cells acclimated to growth in CM (which
contains 2 ng/ml FGF2-see methods) were
cultured on Matrigel-coated 35 mm dishes for
4 days in conditioned medium (CM) or in hESM
(which lacks conditioning or FGF2) at the indicated
concentrations of butyrate. Undifferentiated colo-
nies were scored based on alkaline phosphatase
staining.
(B) Quantitative results from a repeat of the exper-
iment shown in (A) performed in triplicate. Black
line indicates numbers of colonies per dish.
*p < 0.05; **p < 0.01. Red bars indicate percent-
ages of alkaline phosphatase-positive colonies.
Error bars denote standard error of the mean.
(C) Appearance of differentiated cells that appear
transiently after switching from CM to butyrate
for two passages.
(D) Cell-cycle profiles of H1 cells cultured in CM
(left) versus butyrate (right). Numbers indicate
percentages of cells in G1/S/G2. Note increases
in percentages of cells in S and G2 in the butyrate
cultures. These findings are representative of two
independent experiments.
(E) Bromodeoxyuridine (BrdU) incorporation in H1
cells cultured in CM, trichostatin A (TSA) (10 nM)
(*p < 0.05; CM versus TSA), and butyrate
(0.2 mM) (***p < 0.001; CM versus butyrate). Error
bars denote standard error of the mean.
(F) Morphology of H1 cells cultured in CM (F1–F5) or butyrate (F6–F10). (F1) and (F6), on feeders; (F2)–(F5) and (F7)–(F10), on Matrigel; (F3) and (F8), oil red
O-stained; (F4) and (F9), Pou5F1 (Oct4)-stained; and (F5) and (F10), secondary control antibody staining companions to Pou5f1 staining. Note that in (F1),
H1p70(CM28) is 70 passages total, the last 28 of which were without feeder in CM; in (F6), H1p71(B29) is 71 passages total, the last 29 of which were in butyrate;
and for (F7), H1p48(CM3;B6) is 48 passages total, and within the last 9 passages, the first 3 were without feeder in CM and the final 6 passages were in butyrate.
This format is followed for all subsequent figures. The size bar indicates 38 mm in (C) and (F1), and 6 and 15 mm in (F2)–(F5) and (F7)–(F10), respectively.360 Cell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc.tions (>1.0 mM; Boffa et al., 1978) were toxic in hESC cultures
and did not allow for sustained growth (Figures 1A and 1B).
However lower butyrate concentrations (0.2 to 0.3 mM) induced
a transient wave of differentiation (Figure 1C), followed by the
outgrowth of approximately 50% of the original cell population
as undifferentiated hESC that could be maintained in culture
indefinitely (at least 33 passages over 7 months). ESCs are
thought to lack a G1 checkpoint (Savatier et al., 1994; Becker
et al., 2007). H1 cells cultured in hESM with 0.2 mM butyrate
accumulated cells in S and G2, consistent with a relative G2/M
block (Figure 1D). A similar accumulation of cells in G2/M was
recently reported for g-aminobutyric acid (Anda¨ng et al.,
2008). Butyrate-converted hESC divided at about one-quarter
the rate of cells cultured according to standard conditions as
measured by BrdU incorporation (Figure 1E). Notably, 0.2 mM
butyrate was not associated with a significant induction of p21
by real-time quantitative PCR (qPCR; data not shown). Once
acclimated, butyrate-treated cells formed tightly clustered colo-
nies that adhered firmly to Matrigel and lacked the small
percentage of differentiated cells that normally accompany H1
cells cultured in CM (Figure 1F). Butyrate also induced the
appearance of lipid droplets as determined by oil red O staining
(Figure 1F, panel 8).
We confirmed the undifferentiated features of butyrate-
converted H1 cells by assessing a series of ESC-specific
markers and by measuring telomerase activity (Figure 1F9 and
Figure S1 available online). In total, six different hESC lines (H1representing an earlier developmental stage (Brons et al., 2007;
Tesar et al., 2007).
ESCs and cancer cells employ overlapping signaling networks
(Dreesen and Brivanlou, 2007; Wong et al., 2008; Ben-Porath
et al., 2008), raising the possibility that understanding self-
renewal in ESCs might bring new insights to cancer therapy.
Recently, histone deacetylase (HDAC) inhibitors (HDACi) have
emerged as an important new class of anticancer drug (Xu
et al., 2007). Here, we show that both naturally occurring and
synthetic HDACi promote ESC self-renewal using defined,
serum-free culture conditions. HDACi induce a shift in the gene
expression profiles of human and mouse ESCs toward a state
intermediate between ESCs and EpiSCs. Our results define an
alternative ESC state and point to the existence of an evolution-
arily conserved self-renewal program.
RESULTS
A Narrow Concentration of Sodium Butyrate Maintains
hESCs in an Undifferentiated State
H1 cells cultured on Matrigel-coated dishes were switched from
standard culture conditions (conditioned medium that includes
FGF2; CM) to feeder-free culture in hESC medium (hESM)
without feeder conditioning with a range of sodium butyrate
concentrations. hESM contains a proprietary serum replacer
(KSR, Invitrogen), but lacks FGF2 or other growth factors. We
found that the butyrate concentrations used in most publica-
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HDACi and hESC Self-RenewalFigure 2. Butyrate Supports ESC Self-
Renewal Across Species
(A) H13 cells ([A1] in CM and [A2] in butyrate),
rh366.4 rhesus ESCs ([A3] in CM and [A4] in
butyrate), R1 mouse ESCs ([A5] in LIF and [A6] in
butyrate).
(B) Cell-cycle profile of R1 cells cultured in LIF (left)
or butyrate (right).
(C) BrdU uptake in R1 cells cultured in LIF versus
butyrate. **p < 0.01. Error bars denote standard
error of the mean.
(D) Alkaline phosphatase staining (D1 and D4),
Pou5f1 (Oct4) staining (D2 and D5), and phase-
contrast microscopy (D3 and D6) of R1 cells
cultured in LIF (D1–D3) or 0.2 mM butyrate
(D4D6).
(E) Chimeric mouse generated from R1 ESCs
cultured for three passages in butyrate plus LIF
on feeders (E1) and its progeny (E2), indicating
100% germ line transmission (note: all are brown).
Chimeric mouse from mEpiSC line no. 5, a gift
from Paul Tesar and Ron McKay (Tesar et al.,
2007), cultured for 18 passages on feeders with
the addition of butyrate for the last 8 passages
(panel 3). The size bar indicates 38 mm for (A)
and (D).Differentiation Potential of Butyrate-Treated ESCs
Teratomas generated by butyrate-converted hESCs were
complex, containing prominent carrot-shaped cells with rod-
shaped cytoplasmic granules, consistent with melanin contain-
ing pigmented ectoderm (both in H1 and BG02 cells), while the
CM exposed counterparts rarely contained identifiable melanin
(Figure S4). Tomore rigorously evaluate the differentiation poten-
tial of ESCs exposed to butyrate, we used mESCs. We added
butyrate to mESC (R1) cultured on feeders supplemented with
LIF for three passages, and these cells contributed to multiple
tissues in twohigh-level chimeras, including thegermline (Figures
2E1 and 2E2). In addition, two different gene-targeted mESC
clones that had not previously contributed to coat-color chime-
rism using standard culture conditions were able to generate
high-level chimeraswhenbutyratewasadded toMEF-containing
cultures (Table S2). These clones did not contribute to the germ-
line, likely due to pre-existing abnormalities. Additionally, we
were able to derive a new C57BL/6 mESC line in the presence
of butyrate on MEFs that contributed extensively to coat-color
chimerism (Table S2). While mESCs cultured in butyrate in
MEF-free conditions did not generate chimeras (data not shown),
our results demonstrate that adding butyrate to MEF-containing
cultures can maintain and may even augment the ability of
mESCs to contribute to various tissues in vivo.
Butyrate-Induced Transcriptional Response in hESCs
We used whole-genome arrays to compare the transcriptomes
of feeder-free H1 cells cultured according to three conditions
(each in triplicate): (1) standard culture conditions (CM with
2 ng/ml bFGF on Matrigel; H1p48[CM9]) (Group A); (2) cells
from the same pool as group A converted to butyrate for six
passages (hESM with 0.2 mM butyrate on Matrigel;
H1p48[CM3;B6]) (group B); and (3) cells from the same pool as
group B cultured in butyrate for four passages, then reverted
back to standard culture conditions for three passages[National Institutes of Health designationWA01], H9 [WA09], H13
[WA13], BG02, BG03, hSF6 [UC06]) and a rhesus ESC line
(rh366.4) were converted to butyrate-dependent, MEF/CM-
independent culture conditions in hESM supplemented with
0.2 to 0.3 mM sodium butyrate, but lacking FGF2 or other growth
factors (Figure 2A; Table S1). We observed differences among
hESC lines in their responses to butyrate. BG03 cells were
readily converted to butyrate, with little evidence of differentia-
tion. H1 cells were more fastidious, requiring dense plating prior
to butyrate exposure and 1:1 passaging (for at least 2 passages)
after butyrate addition. The concomitant presence of feeder cells
eased the conversion of some (H9), but not all (H1, BG02, and
BG03), hESC lines. The emergence of karyotypic abnormalities,
common in hESC cultures (Denning et al., 2006; Ware et al.,
2006; Baker et al., 2007), occurred in butyrate cultures at rates
similar to CM (Table S1 and Figure S2). Although trisomy 17 is
a common abnormality in hESC cultures (Baker et al., 2007),
we have not observed trisomy 17 in butyrate-treated hESCs.
Notwithstanding the well-established differences between the
self-renewal programs of mouse and human ESCs, butyrate also
promoted the extensive self-renewal of amESC line (R1) (Figures
2A and 2D). mESCs cultured in butyrate-containing medium
without LIF (see the Experimental Procedures) adopted a very
similar appearance to mESCs cultured in LIF. In both conditions,
scattered differentiated cells at the colony periphery surrounded
undifferentiated cells located centrally. In mESC, butyrate
slowed the rate of cell division without perturbing the cell cycle
(Figures 2B and 2C). Based on the resulting hypothesis that
butyrate-induced ESC self-renewal arises from a common,
evolutionarily conserved mechanism, we predicted that buty-
rate-induced self-renewal of mESCs could occur in the absence
of LIF signaling. Confirming this prediction, we showed that
mESCs lacking either the LIF receptor specific subunit or its
shared gp130 partner could be converted to butyrate culture
conditions (Figure S3).Cell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc. 361
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HDACi and hESC Self-Renewal(H1p49[CM3;B4;CM3]) (group C). Groups A and B and groups B
and C were directly compared on Agilent arrays. A supervised
cluster analysis readily distinguished the three groups
(Figure S5). Butyrate significantly regulated 479 genes: 250
were upregulated, and 229 were downregulated (https://depts.
washington.edu/iscrm/GS_data/gsdata.html). The large number
of downregulated transcripts is consistent with a recognized
but poorly understood role for butyrate in gene repression
(Rada-Iglesias et al., 2007). The top 15 upregulated and downre-
gulated genes are shown in Table S3. qPCR confirmed the differ-
ential regulation of all 14 representative genes tested
(Figure S6A). Butyrate strongly induced several embryonic-
and germ-cell-associated transcripts including Dppa5 (Esg1),
Piwil2, Bnc1, Lrrc8e, Mbd3, and Ecat8 while downregulating
Tcf3 and Gata6 (Table S4). Dppa5, Piwil2, Ecat8, Ddx25, and
Ddx43 all encode RNA-binding proteins, while Mbd3 is a part
of the nucleosome remodeling and histone deacetylation
(NuRD) corepressor complex associated with cell-fate deci-
sions and pluripotency (Kaji et al., 2007). Dppa5 and Ddx43/
HAGE, the first and second most strongly induced genes, are
spaced 60 kilobases apart on chromosome 6, and Ecat1 is
positioned between them. While Ecat1 was not represented
on the microarray, we found that it is also induced by butyrate
(Figures 6B and 6C).
Several members of the canonical Wnt signaling pathway
were downregulated by butyrate, including Wnt3, Tcf3, Frzb,
and Sfrp2, as were b-catenin targets Sp5 (Weidinger et al.,
2000), Gad1 (Li et al., 2004), Fst (Yao et al., 2004), Lefty1 (Tabib-
zadeh and Hemmati-Brivanlou, 2006), Pitx2 (Zirn et al., 2006),
and Id2 (Willert et al., 2002). An increase in Inhba (INHBA homo-
dimerizes to form ACTIVIN A) and reduced expression of Lefty1
and Fst indicate that the TGFb pathway may be recruited to
maintain self-renewal of butyrate-treated hESCs (Vallier et al.,
2005; Xiao et al., 2006; Eiselleova et al., 2008). Butyrate treat-
ment also resulted in downregulation of Tcf3, a repressor of
Nanog in mESCs (Pereira et al., 2006; Yi et al., 2008). While
butyrate did not induce a significant change in Nanog levels,
we found Nanog to be consistently (albeit subtly) elevated in
hESCs cultured in butyrate relative to CM (Figure S1B). NANOG
stabilizes ESCs in culture, underpinning the epigenetic erasure
unique to pluripotent and germ cells (Chambers et al., 2007).
A subtle rise in Nanog may reflect the absence of differentiating
cells in butyrate-acclimated cultures.
Withdrawal from feeder cells was not necessary to elicit the
butyrate transcriptional program, sinceDppa5, Ecat1, and Piwil2
were all induced in H13 cells three passages after adding buty-
rate to feeder-containing cultures (Figure S6B). Approximately
85% of genes that were differentially expressed in response to
butyrate (group B versus group A) (Figure 3A) returned promptly
to near-baseline levels after reverting back to standard culture
conditions (group C versus group A) (Figure 3B). Conversely,
some butyrate-responsive genes remained persistently altered
following three passages in CM (Figure 3B and Table S4). Persis-
tently induced genes included Dppa5, Ddx43/HAGE, and Ecat1
(Figure S6C). The basis for this persistent effect on the expres-
sion of some genes long after butyrate withdrawal suggests
the presence of distinct mechanisms for regulating these genes.
A significant overlap in butyrate-regulated genes occurred
between H1 cells and a second hESC line, BG02 (Figure 3C).362 Cell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc.The similar transcriptional responses between H1 and BG02
were highly significant (p < 0.0001).
A Distinct Transcriptional Response to Butyrate
in mESCs
Wealso compared the transcriptional profiles ofmESCs cultured
according to our standard MEF-free culture conditions (the
medium was identical to hESM, except that 20% fetal bovine
serum substitutes for serum replacer, plus the addition of LIF)
versusbutyrate (using the samemediumwithout LIF). Supervised
cluster analysis distinguished the two groups (Figure S7).
Strikingly, there was very little overlap between the lists of
butyrate-regulated genes in mESCs and hESCs (https://depts.
washington.edu/iscrm/GS_data/gsdata.html). Even genes that
were dramatically induced by butyrate in hESCs (Dppa5,
Ddx43/HAGE, andPiwil2) wereunchangedor evenverymodestly
downregulated (in the case of the Piwil2 homologMili) in mESCs.
Butyrate Induces theConvergence of hESCs andmESCs
toward a Common Developmental Intermediate
Two recent reports described the derivation of epiblast stem
cells (EpiSCs) from postimplantation mouse blastocysts and
that EpiSCs more closely resemble hESCs than do mESCs
(Brons et al., 2007; Tesar et al., 2007). We reasoned that the
contrasting effects of butyrate on the transcriptional profiles of
hESCs versus mESCs might be reconciled if butyrate brought
both hESCs and mESCs nearer one another toward a develop-
mental stage intermediate between mESCs and mouse EpiSCs
(mEpiSCs). To test this hypothesis, we correlated butyrate-
induced transcriptional responses in hESCs and mESCs with
the published transcriptional profiles ofmESCs versusmEpiSCs.
Figures 3D–3F present identical scattergrams (black dots)
comparing the relative levels of gene expression from published
mRNA microarrays of mESCs (x axis) versus EpiSCs (y axis)
(Tesar et al., 2007). In Figures 3D and 3E, mouse homologs of
genes that are significantly induced or repressed by butyrate in
H1 and BG02 cells are overlaid as red or green dots, respec-
tively. Note that butyrate-induced genes in hESCs (red) are
homologous to genes that tend to be more highly expressed in
mESCs and localize nearer the x axis, whereas homologs of
butyrate-repressed transcripts (green) tend to bemore abundant
in EpiSCs. This correlation is consistent with the interpretation
that butyrate shifts the transcriptional program of hESCs away
from EpiSCs and toward mESCs. Strikingly, Figure 3F shows
the opposite pattern in the mESC line R1: genes that are signif-
icantly induced by butyrate in mESCs (red) tend to be more
highly expressed in EpiSCs, whereas butyrate-repressed genes
tend to be expressed at higher levels in mESCs. Figure 4 shows
results for ESC-associated genes, comparing butyrate
responses in hESCs with the relative expression levels of their
mouse homologs in mESCs versus EpiSCs. These patterns
were highly significant and support the initial observation that
mEpiSCs and hESCs equate to a similar embryonic stage with
mESCs positioned earlier (Brons et al., 2007; Tesar et al.,
2007) and that butyrate advances mESCs and retracts hESCs
toward a developmental state intermediate between mESCs
(inner cell mass, ICM) and hESCs (epiblast).
To further examine the hypothesis that butyrate exposure pulls
hESCs andmEpiSCs backward toward an earlier developmental
Cell Stem Cell
HDACi and hESC Self-RenewalFigure 3. Transcriptional Responses to Butyrate in Human and Mouse ESCs
Colored dots depict genes that are significantly upregulated (red) or downregulated (green) in response to butyrate in the hESC lines H1 (A–D) and BG02 (E), and
the mESC line R1 (F).
(A) Scatter plot depicting the transcriptional response of H1 cells cultured for six passages in butyrate versus H1 cells maintained in CM (see text for details).
(B) Reversion toward the original pattern of expression after returning butyrate-treated H1 cells back to CM for three passages (‘‘Reconditioned Medium’’).
(C) Scatter plot depicting the transcriptional response to butyrate in BG02 cells (black dots), with red and green dots identifying those genes that were butyrate-
regulated in H1 cells, to highlight genes that were coordinately regulated in both hESC lines.
(D–F) Scatter plots (in black) depicting average expression levels in mEpiSCs versus mESC (from Tesar et al., 2007; identical for all three panels). (D) and (E) over-
lay butyrate responsive homologous genes in H1 and BG02 cells, respectively. Colored dots indicate homologous genes in the hESC lines that were significantly
upregulated (red) or downregulated (green) in response to butyrate. (F) overlays butyrate-responsive genes in mESCs. Colored dot overlays indicate genes in
mESCs (R1 cells) that were significantly upregulated (red) or downregulated (green) in response to butyrate. Note that butyrate pulls the gene expression profile
of hESCs toward mESCs (x axis) and away from mEpiSCs (y axis) while pushing mESCs toward EpiSCs; thus, the relative orientation of red and green dots
between (D) and (E) versus (F) is reversed. Two sample t tests assuming equal variance indicate that these changes are highly significant ([D], t = 9.921; [E]:
t = 4.88; [F], t = 11.139; p < 0.001; see Supplemental Experimental Procedures).dependency nor feeder independency in mEpiSCs (data not
shown), its presence did allow anmEpiSC line provided by Tesar
and McKay to generate a single coat-color chimera in 14 pups
(48 blastocysts injected; Figure 2E3).
Butyrate Induces H3K9 Acetylation and CpG
Demethylation at the Dppa5 Promoter
We examined the epigenetic responses of a number of butyrate-
regulated genes using chromatin immunoprecipitation (ChIP)
assays. The promoters of some (Dppa5, Ddx43, and Rcn3), but
not all (Cxcl5), butyrate-induced genes displayed a correspond-
ing rise in H3K9 acetylation, whereas repressed genes showed
little change (Dusp6 and Ier5) or a decline (Sp5) in H3K9 acetyla-
tion (Figure 7A). Bisulfite sequencing of the Dppa5 promoter
showed a striking decline in DNA methylation in H1 cells treated
with butyrate, and a very similar response occurred in BG02 cells
(Figure 7B). For both hESC lines, the residual methylation in
butyrate-treated cells was concentrated among a few clones,
consistent with a butyrate-induced inhibition of Dppa5 methyla-
tion following DNA replication. Serial monitoring of the Dppa5
promoter at various time points following butyrate exposurestage, we performed additional studies. Some female hESC lines
harbor an inactive X chromosome, reflected in the presence of
Xist bodies (International Stem Cell Initiative et al., 2007; Hall
et al., 2008). Xist expression is abundant in later passage H9 cells
(p77) cultured on feeders (92 of 104 cells scored [88.5%]), but
was undetectable in H9 cells cultured for 31 passages in hESM
plus butyrate (0 of 108 cells scored [0%]) (Figure 5, panels
1–7). However Xist was expressed in butyrate-treated H9 cells
after 21 days of differentiation (Figure 5, panels 8–11). We also
found that butyrate-treated hESCs differentiated more gradually
than hESCs cultured in CM, as evidenced by a slower decline in
302 family miRNAs (Figure 6A) and by a delay in directed differ-
entiation toward retinal neurons (Lamba et al., 2006; Figure 6B).
This butyrate-induced differentiation delay was reversed in part
by returning butyrate-exposed cells to CM for three passages
prior to differentiation (Figure 6B).
We also tested butyrate’s effect on mEpiSCs (Tesar et al.,
2007; Figure S8). Hallmark functional differences between
mESCs and mEpiSCs include the latter’s nonresponsiveness
to LIF and markedly reduced ability to generate chimeras (Brons
et al., 2007; Tesar et al., 2007). While butyrate did not induce LIFCell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc. 363
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HDACi and hESC Self-RenewalFigure 4. Transcriptional Changes Induced by Butyrate in hESC Correlate with the Relative Abundance of Their Homologues in mESCs
Relative to EpiSCs
Differences in expression levels of 87 ESC-related genes between H1 cells cultured in butyrate [H1p48(CM3;B6)] versus CM [H1p48(CM9)] (butyrate/CM, orange
bars) and mESC versus EpiSCs (ES/EpiSC, green bars from Tesar et al., 2007). y axis indicates Log 2 fold change. Spearman’s rho correlation coefficient for the
two data sets is 0.42. p < 104.revealed no change in DNA methylation by day 7; however,
significant declines were observed on days 14 and 28
(Figure 7C). These kinetics are also consistent with a replica-
tion-dependent decline in DNA methylation.
HDACi and ESC Self-Renewal
Other HDACi also supported hESC self-renewal. Trichostatin
A (TSA) supported H1 cells for more than 30 passages
(Figure S9A), whereas valproic acid (0.5 mM) was effective only
in maintaining hESCs previously converted to butyrate culture
conditions. Each HDACi induced a subtly different, but revers-
ible, colony morphology, most apparent at the colony edges.
Butyrate, butyryl CoA (the retained derivative of butyrate uptake
in mitochondria), suberoylanilide hydroxamic acid (vorinostat/
SAHA), and TSA-exposed cells plated tightly with sharply
demarcated edges, whereas some cell spread at the edges
was seen in CM. Stretching of cells at the colony edge was
also observed in response to valproic acid. hESC cultured in
Figure 5. Butyrate Cultures Are Associated
with a Lack of Xist
Dapi nuclear stain indicating the presumptive
presence of the condensed X chromatin (arrows,
[1]) and accompanying Xist expression (arrows,
[2] and [3]) in later passage H9 cells. The same
cells grown for the last 31 passages in butyrate
on feeders did not show condensation of the
X chromatin ([4] and [6]) or Xist ([5] and [7]). Below
(1)–(7) are the corresponding counts of Xist-
positive versus -negative cells on the coverslips.
Dapi staining of earlier passage H9 cells grown
on feeders with one passage in CM shows
evidence of X-inactivation upon differentiation for
21 days ([8], Dapi, and [9], Xist). Cells grown for
three passages in butyrate followed by differentia-
tion for 21 days in the absence of butyrate showed
clear evidence of appropriate Xist body formation
induced by differentiation ([10], Dapi, and [11],
Xist). Arrows depict location of condensed
chromatin (Dapi) and Xist bodies (green, Xist).
The size bar indicates 5 mm.364 Cell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc.
Cell Stem Cell
HDACi and hESC Self-RenewalTSA or valproic acid divided more rapidly than in butyrate, but
not as rapidly as in CM, and were free of lipid-containing
vacuoles (data not shown). These findings indicate that as
a class, HDACi can promote the self-renewal of ESCs. Suggest-
ing a common mechanism of action, TSA induced a similar, but
not identical, transcriptional response in a panel of 18 butyrate
responsive genes (Figure S9B). In contrast to butyrate, TSA did
not promote improved chimera formation in mice and did not
appear to support the long-term maintenance of mESCs without
LIF or feeders. We conclude that while not all HDACi share
butyrate’s full spectrum of activity, HDAC inhibition is at the
core of butyrate-induced ESC self-renewal.
DISCUSSION
We show that ESCs can extensively self-renew in response to
butyrate, without need for feeder conditioning or recombinant
growth factors. ESCs are exquisitely sensitive to butyrate, and
self-renewal occurs only within a narrow concentration range,
with higher concentrations (prevalent in the literature) inducing
Figure 6. hESCs Cultured in Butyrate Differen-
tiate More Slowly than hESCs Cultured in CM
(A) Time course of 302 family member miRNA
expression in H1 cells during an 8 day course of differ-
entiation. Top panels: H1 cells cultured in CM prior to
differentiation [H1p69(CM14)]. Bottom panels: H1
cells cultured in butyrate prior to differentiation
[H1p67(B15)]. Note that butyrate-treated H1 cells
exhibit a slower decline in 302 family miRNAs with
differentiation compared to H1 cells cultured in CM.
(B) qRTPCRof differentiation-associated transcripts in
H1 cells cultured according to a previously published
neuroretinal differentiation protocol (Lamba et al.,
2006). Blue bars, H1 cells cultured in CM for eight
passages; orange bars, H1 cells cultured in butyrate
for eight passages; red bars, H1 cells cultured in
butyrate for six passages and reverted to CM for three
passages. Pax6, Six3, Lhx2, and Crx are associated
with retinal differentiation.
differentiation. Since other HDACi (TSA, val-
proic acid, and vorinostat) also promote ESC
self-renewal, our results point to the exis-
tence of a core machinery for ESC self-
renewal that is under HDAC control and
that can be activated upon HDAC inhibition.
Nonetheless, we do note differences in the
response of ESCs to various HDACi. For
example, TSA did not allow mESC to
develop appropriately in the embryo to
generate chimeras, and valproic acid could
only maintain hESCs in culture that had
already been converted to butyrate. We
cannot discern whether these differences
reflect butyrate’s potency or range of
HDAC inhibition, or additional activities
beyond HDAC inhibition. Within cells, buty-
rate is converted to butyryl CoA, which we
showcan also support hESC self-renewal. Butyryl CoA is integral
to mammalian metabolism both for immediate energy and for
energy storage and can be utilized to build triacylglycerols and
phospholipids, the likely contents of the oil red O+ droplets
present in butyrate-treated cells.
The transcriptional response to butyrate in hESCswas distinc-
tive, as exemplified by Dppa5. Butyrate induced a number of
embryonic/cancer/testes-associated genes in hESCs, including
Dppa5 and its neighbors Ddx43/HAGE and Ecat1. A CpG island
upstream of Dppa5, unmethylated in sperm and testes, is
densely methylated in peripheral blood (Shen et al., 2007) and
in hESCs cultured in CM (Figure 7). Butyrate treatment dramati-
cally reduced methylation of this CpG island, providing the first
example, to our knowledge, of CpG demethylation in response
to an HDACi (Cameron et al., 1999). This demethylation was
highly context dependent since other induced genes (Ddx43,
Rcn3, and Cxcl5) were only modestly demethylated and Sp5,
a repressed gene, was moderately hypermethylated in response
to butyrate (preliminary observations). Butyrate also prevented
the appearance of Xist expression in later passage H9 cells,Cell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc. 365
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HDACi and hESC Self-RenewalFigure 7. Epigenetic Responses to Butyrate
(A) H3K9 acetylation in the promoters of butyrate-responsive genes. Light gray bars indicate BG02 cells cultured in CM [BG02p74(CM35)]; dark gray bars indicate
BG02 cells cultured in butyrate [BG02p79(CM29;B24)]. An antibody directed against total histone H3 provided a control.
(B) Bisulfite sequencing of the Dppa5 promoter in H1 cells (left) and BG02 cells (right). Closed circles indicate the presence of methylation, and open circles
indicate the absence of methylation. Numbers indicate the distance upstream from the transcription start site. Comparisons were made between
H1p77(CM43) versus H1p84(B42) (left panels) and BG02p49(CM10) versus BG02p76(CM29;B18) (right panels).
(C) Changes in Dppa5 promoter methylation at various time points following a switch from CM [H1p63(CM8)] to butyrate. Open circles indicate methylation levels
in butyrate-treated cells, whereas the closed circle depicts Dppa5 promoter methylation in the same cells continuously cultured in CM.366 Cell Stem Cell 4, 359–369, April 3, 2009 ª2009 Elsevier Inc.beyond the range of interconvertible ESC states (Hayashi et al.,
2008).
Whether the effects described here have a corollary in vivo is
not known. A potential physiological underpinning is suggested
by the conservation of butyrate responsiveness from mouse to
human ESCs and mEpiSCs. Our data suggest that butyrate
may fine-tune peri-implantation development. That butyrate-
treated mouse ESCs retain the ability to contribute to chimeric
mice, including transmission to the germline, indicates that buty-
rate effects are fully reversible and exert no obvious harm on
embryonic development. Butyrate exposure improves the ability
of previously unsuccessful mESC clones to generate chimeras;
thus, butyrate confers an ability to survive and contribute appro-
priately in the context of the blastocyst. That thesemESC clones,
in the absence of butyrate, are unable to generate chimeras
(although pups are born) suggests that they do not integrate or
participate in normal development and can only respond appro-
priately with the assistance of butyrate.
Our results demonstrate that butyrate and other HDACi can
shape the ESC state. Cross-species convergence toward
a common ESC state raises the possibility of an as yet undiscov-
ered physiological signaling axis that involves butyrate or
analogous molecules that can potently regulate development.
EXPERIMENTAL PROCEDURES
hESC Culture
Initial cultures of hESC (H1 [NIH code WA01], H7 [WA07], H9 [WA09], H13
[WA13], hSF6 [UC06], BG02, and BG03) and nonhuman primate (rh366.4)
ESCs were grown on a feeder layer of g-irradiated (3000 rads) primary mouse
embryonic fibroblasts (MEF) (Abbondanzo et al., 1993). For cultures without
feeders, cells were plated on Matrigel (BD Biosciences) diluted according to
manufacturer’s instructions. Human ESC culture medium (hESM) consisted
of DMEM/F12-containing GlutaMax supplemented with 20% serum replacer
(SR), 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 50 U/mlsuggesting an inhibitory effect on X inactivation. In general, the
induction of butyrate-responsive genes is rapidly reversed
following butyrate withdrawal (Davie, 2003). However, another
unusual feature of the butyrate response observed here was
the very gradual return of a subset of butyrate-regulated genes
back to baseline after reverting hESCs back to CM (Figure 3B;
Figure S6C; Table S4). This slow return to baseline demonstrates
the existence of a mechanism for the prolonged transcriptional
memory of butyrate exposure.
The most surprising finding from our study was the contrast
between butyrate’s ability to support ESC self-renewal across
species, while eliciting virtually nonoverlapping transcriptional
responses in hESCs versus mESCs. Our gene expression anal-
ysis strongly supports the conclusion that HDACi push mESCs
forwardandpull hESCsbackward towardadevelopmental corol-
lary intermediate between ESCs and EpiSCs. Other reports
support the existence of alternative ESC-like states. Culturing
mESCs inmediumconditionedbyHepG2cellswas found to elicit
a gene expression profile similar to early primitive ectoderm, with
induction of Fgf5 and repression of Rex1, Stella/Dppa3, and
Pecam1 (Rathjenet al., 1999). Theseearlyprimitiveectoderm-like
(EPL) cells could not form chimeric mice yet reverted back to an
ESC-like state (regaining chimera-forming ability) upon return to
LIF. Very recently, another group used a GFP reporter under
control of a Stella/Dppa3 promoter to identify large numbers of
STELLA-negative, PECAM1-negative ESCs in LIF-containing
cultures (Hayashi et al., 2008). While chimera-forming ability
was not tested, the STELLA-negative population reverted to
more of an ESC-like state when cultured in the presence of
feeders or TSA. In contrast to these published reports, the alter-
native ESC state induced by butyrate appears to be better able
to generate chimeric mice. While butyrate might also enhance
the poor chimera-forming ability of EpiSCs, it does not convert
EpiSCs to mESCs, consistent with the notion that EpiSCs fall
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HDACi and hESC Self-Renewalpenicillin, 50 mg/ml streptomycin, (all from Invitrogen, Carlsbad, CA), and 0.1
mM b-mercaptoethanol (Sigma, St. Louis, MO). Conditioned medium (CM)
was made by incubating hESM in the presence of MEF as described in the
Supplemental Experimental Procedures. CM also included 2 ng/ml basic
FGF (FGF2, Peprotech, Rocky Hill, NJ, USA). hESCs cultured in the presence
of 0.2 to 0.3 mM sodium butyrate (Sigma) were cultured in hESM in the
absence of MEF conditioning or FGF2. Concentrations of other HDACi were
10 nM TSA, 0.5 mM valproic acid, 10 mM butyryl CoA (all from Sigma), and
400 nM vorinostat (Cayman Chemical, Ann Arbor, MI). Nomenclature for
culture conditions follows the following convention: cell line, total passage
number (number of passages off of feeders, where CM indicates culture on
Matrigel in conditioned medium and B indicates culture in butyrate—generally
on Matrigel with no feeder or added FGF—followed by the number of
passages under a different growth medium, etc.). Thus, H1p62(CM4;B6;CM3)
would be H1 grown for 62 passages overall. Of the last 13 passages, all were
onMatrigel without feeders, and passages 49–52were in CM, passages 53–59
were in butyrate, and passages 60–62 were in CM. Occasionally, hESCs were
cultured in butyrate on MEFs. When this was done, it is listed in the text.
mESC Culture
mESCs were cultured in the same medium described for hESC, except the
serum replacer in human medium was substituted with 20% FBS (ES Cell
Qualified, Invitrogen). MEF: free cultures were performed on gelatin-coated
dishes using medium supplemented with 1000 units/ml mouse LIF (ESGRO,
Chemicon) or butyrate (0.2 mM). On occasion, butyrate was added to mESC
cultured onMEF. Cultures of LIF receptor null mESCs (a gift fromAustin Smith),
gp130 null mESCs (a gift from Ian Chambers), and derivation of mESCs were
performed as described in the Supplemental Experimental Procedures.
mEpiSC Culture
Mouse EpiSC line no. 5 (a gift fromPaul Tesar and RonMcKay) was cultured as
described (Tesar et al., 2007). In addition, new mEpiSC lines were derived as
previously described (Tesar et al., 2007).
Immunohistochemistry and Flow Cytometry
Maintenance of an undifferentiated phenotypewas established by immunohis-
tochemistry using antibodies for Oct-4 (R&D Systems; 1:200 dilution) and
SSEA-4 (Chemicon; 1:50 dilution) and by staining for alkaline phosphatase
(AP) activity using a Black Alkaline Phosphatase Substrate Kit II (Vector
Laboratories). Flow cytometry was performed using a FACScan flow cytome-
ter and Cell Quest software (BD Biosciences) and the following antibodies:
anti-SSEA4, anti-TRA-1-60 and TRA-1-81 (Chemicon), and anti-SSEA-3
(R&D Systems). For cell-cycle analysis, cells were harvested, washed with
phosphate-buffered saline (PBS), and fixed in 70% ethanol. Fixed cells were
stained with propidium iodide (PI), and DNA content was measured by the
intensity of the fluorescence produced by PI. Data were analyzed with the
Modfit 3.0 software (Verity House Software).
Quantitative PCR
Total RNA was purified using the RNeasy Micro Kit (QIAGEN) following the
manufacturer-specified protocol. Reverse transcription of total RNA was
performed using random hexamers with the SuperScript III First-Strand
Synthesis System for RT-PCR (Invitrogen). Quantitative PCR was performed
in triplicate using TaqMan Universal PCR Master Mix, No AmpErase UNG
(Applied Biosystems), or SYBR Green PCR Master Mix (Applied Biosystems)
in 25 ml reactions in an Applied Biosystems 7900HT Fast Real-Time PCR
System. Settings and primer sequences are described in the Supplemental
Experimental Procedures.
Microarray Analysis
Agilent whole-human genome arrays were hybridized with total RNA from H1
cells cultured in each of the following conditions (2 arrays per condition): (1)
Cultured onMatrigel on CM; (2) cultured for 6 passages in butyrate; (3) cultured
for 3 passages in butyrate, followed by 3 passages in CM. Group 1 was
compared to 2 in independent triplicate, and 2 was compared to 3 in indepen-
dent triplicate. Thus, by experimental design and Agilent platform, Groups
1 and 3 served as controls relative to 2. Agilent whole-mouse genome micro-
arrays were hybridized with total RNA from R1 cells cultured on gelatin withoutfeeder support in LIF or R1 cells cultured in 0.2 mM butyrate without LIF or
feeder support. These were run in independent quadruplicate.
Geneswere defined as differentially expressed if they showed both a change
in expression at a false discovery rate of 0.2 as analyzed by an empirical paired
t test and a 1.5-fold change in expression level. Genes were matched across
the mouse and human data sets using Homologene. See the Supplemental
Experimental Procedures for more details.
Bisulfite-Sequencing Analysis of Promoter Methylation and
Chromatin Immunopreciptation Analysis of Promoter Acetylation
Bisulfite-sequencing to assess Dppa5 promoter methylation was performed
as reported previously (Shen et al., 2007). Chromatin immunoprecipitation
(ChIP) analysis to assess promoter acetylation was performed as described
(Nelson et al., 2006) and utilized an anti-acetyl-histone H3 antibody, which
recognizes lysine residues 9 and 14 (Millipore).
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